Surgical Outcomes of Concomitantly Performed Penetrating Keratoplasty with Intrascleral Haptic Fixation
Overview
Authors
Affiliations
Purpose: : To describe the surgical results of concomitantly performed optical penetrating keratoplasty (PKP) with glued intrascleral haptic fixation (ISHF).
Methods: : Retrospective review of 18 patients (15-72 years) with best-corrected visual acuity (BCVA) of ≤1/60 subjected to unilateral concomitant optical PKP with ISHF and followed up for 13.11 ± 5.83 months (6-26 months) was undertaken.
Results: : The most common diagnoses were failed PKP (9/18, 50%) followed by aphakic bullous keratopathy (5/18, 27%). Preoperative glaucoma, peripheral anterior synechiae (PAS), and deep vascularization were present in 7/18 (38.88%), 12/18 (61.11%), and 5/18 (27.77%) patients, respectively. Intraoperatively, concomitant procedures such as pupilloplasty and intraocular lens explant were undertaken in 5/18 (27.277%) patients and 1/18 patients (5.55%) experienced suprachoroidal hemorrhage. At final follow-up, BCVA was ≥6/60 in 50% patients (mean astigmatism: 4.79 ± 1.68D), and 55.55% cases experienced graft failure (90% failed within one year of surgery). The most common causes of graft failure were glaucoma (50%), glaucoma with rejection (20%), rejection (10%), retinal detachment (10%), and suprachoroidal hemorrhage (10%). The ODDS ratio (OR) of having graft failure with the following factors was postoperative secondary interventions (OR: 6), postoperative complications (OR: 2.25), prior failed graft (OR: 1.8), preoperative PAS (OR: 1.75), intraoperative concomitant procedures (OR: 1.5), preoperative glaucoma (OR: 1.33), previous surgeries (OR: 1.24), and deep corneal vessels (OR: 0.66).
Conclusion: : All patients underlying PKP combined with glued ISHF must be counseled about suboptimal surgical outcomes. Emphasis is laid on appropriate case selection and stringent follow-up during the first year after surgery. Secondary interventions should be undertaken cautiously and judiciously in these patients.
Almulhim A, Alsarhani W, Alanazi B, Alfaleh A, Aljindan M, Al Malawi R BMC Ophthalmol. 2024; 24(1):337.
PMID: 39135167 PMC: 11318130. DOI: 10.1186/s12886-024-03603-6.
Yang T, Castellanos M J Ophthalmol. 2024; 2024:2718527.
PMID: 38716088 PMC: 11074865. DOI: 10.1155/2024/2718527.
Agarwal R, Shakarwal C, Sharma N, Titiyal J Indian J Ophthalmol. 2023; 71(5):1718-1732.
PMID: 37203023 PMC: 10391482. DOI: 10.4103/ijo.IJO_1724_22.